Department of Pediatrics, Division of Neonatology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Am J Perinatol. 2024 Aug;41(11):1504-1511. doi: 10.1055/a-2118-5351. Epub 2023 Jun 27.
Nasal high-frequency oscillatory ventilation (nHFOV) and synchronized nasal intermittent positive pressure ventilation (sNIPPV) were the new modes of noninvasive ventilation. This study's aim was to clarify as to which of the nHFOV and sNIPPV modes was superior in preventing postextubation failure or reintubation in neonates.
An open-label parallel randomized study was performed. Extubated preterm and term neonates were randomly allocated into nHFOV or sNIPPV modes; the reintubation rate was evaluated within 7 days after extubation between the two modes. Subgroup analyses were performed for preterm (gestational age <37 weeks) and very preterm (gestational age <32 weeks) neonates. The sample calculation was 1,050 neonates; however, this trial was stopped early as enrollment was too slow.
From July 2020 to June 2022, 202 neonates were assessed for eligibility and 69 neonates were excluded. Finally, 133 neonates were randomly allocated to the study interventions (nHFOV = 67, sNIPPV = 66). The median gestational age and birth weight were 33 (30-37) weeks and 1,910 (1,355-2,836) g, respectively. The reintubation rate within 7 days did not significantly differ between the groups (nHFOV [5/67, 7%] vs. sNIPPV [4/66, 6%]); risk difference [95% confidence interval] = 0.01 [-0.08 to 0.11]; = 0.99), including preterm (nHFOV [4/55, 7%] vs. sNIPPV [3/44, 7%]) and very preterm (nHFOV [3/25, 12%] vs. sNIPPV [3/25, 12%]) neonates.
After neonatal extubation, there was no significant difference of reintubation rates within 7 days between nHFOV and sNIPPV. This trial has been registered in the ClinicalTrials.gov database ( https://clinicaltrials.gov/ct2/show/NCT04323397 ). First posted registration on March 26, 2020.
· There was no significant difference of reintubation rates between nHFOV and sNIPPV.. · During nHFOV support, one neonate developed pneumomediastinum.. · During sNIPPV support, one neonate developed pulmonary hemorrhage..
鼻腔高频振荡通气(nHFOV)和同步间歇正压通气(sNIPPV)是两种新型的无创通气模式。本研究旨在明确 nHFOV 和 sNIPPV 模式中哪一种在预防新生儿拔管后失败或再插管方面更具优势。
这是一项开放标签、平行随机研究。将已拔管的早产儿和足月儿随机分配至 nHFOV 或 sNIPPV 模式;在拔管后 7 天内评估两种模式之间的再插管率。对早产儿(胎龄 <37 周)和极早产儿(胎龄 <32 周)进行亚组分析。样本量计算为 1050 例新生儿,但由于入组速度太慢,该试验提前停止。
2020 年 7 月至 2022 年 6 月,对 202 例新生儿进行了入选评估,其中 69 例被排除。最终,133 例新生儿被随机分配至研究干预组(nHFOV [67 例]、sNIPPV [66 例])。中位胎龄和出生体重分别为 33(30-37)周和 1910(1355-2836)g。两组 7 天内的再插管率无显著差异(nHFOV [5/67,7%] vs. sNIPPV [4/66,6%]);风险差异[95%置信区间] = 0.01 [-0.08 至 0.11]; = 0.99),包括早产儿(nHFOV [4/55,7%] vs. sNIPPV [3/44,7%])和极早产儿(nHFOV [3/25,12%] vs. sNIPPV [3/25,12%])。
新生儿拔管后,nHFOV 和 sNIPPV 两组 7 天内的再插管率无显著差异。该试验已在 ClinicalTrials.gov 数据库(https://clinicaltrials.gov/ct2/show/NCT04323397)注册。首次注册日期为 2020 年 3 月 26 日。
nHFOV 和 sNIPPV 两组再插管率无显著差异。
nHFOV 支持期间,1 例新生儿发生纵隔气肿。
sNIPPV 支持期间,1 例新生儿发生肺出血。